Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

FDAnews Announces: FDA Recordkeeping, Dangerous Documents and Writing for Compliance ™, Nov. 13-14, Bethesda, MD
  • USA - English


News provided by

FDANEWS

Oct 14, 2013, 03:00 ET

Share this article

Share toX

Share this article

Share toX

FDA Recordkeeping, Dangerous Documents and Writing for Compliance
FDA Recordkeeping, Dangerous Documents and Writing for Compliance

Falls Church, VA (PRWEB) October 14, 2013 -- FDA Recordkeeping, Dangerous Documents and Writing for Compliance ™
**Presented by FDAnews**
Nov. 13-14, 2013 – Bethesda, MD
http://www.fdanews.com/FDARecordkeeping

Every day, people write casual emails, meeting minutes and sticky notes, never anticipating that an FDA inspector or other third party will read them. But these are exactly the types of correspondences that are often used to determine an organization’s overall compliance profile.

“Dangerous Documents is a fantastic presentation, filled with real-world examples of what not to do.” -- Senior Regulatory Affairs Specialist, ACell, Inc.

Post this

And thanks to product liability lawyers, these notes also need to be defensible…from criminal actions and lawsuits. A simple and harmless phrase such as “This will negatively impact our bottom line,” can be the key piece of evidence against you in a product liability case.

But don’t be afraid to write the next email. Join FDAnews on Nov. 13-14 for a two-day intensive workshop:FDA Recordkeeping, Dangerous Documents and Writing for Compliance™.

This is not a typical workshop

Instead of sitting and being lectured to, participants will engage in case studies, role playing, real-life examples and exercises designed to ensure that the written word not only properly reflects compliance initiatives, but also prevents trouble. Attendees will leave this workshop knowing:

  • Who in your company could be held criminally liable for record deficiencies
  • Core requirements for keeping records
  • Questions FDA investigators ask to determine the trustworthiness of records
  • Expectations for digital versus paper records
  • Email’s risks
  • How to establish an effective records retention schedule
  • Proper ways of handling supplier and CAPA records
  • How to balance long-term storage challenges — paper and digital
  • FDA-approved techniques for disposing of records

BONUS - Attendees will receive a USB drive that contains more than 100 checklists, SOPs, cheat sheets, ready-to-use forms, policy papers, guidances, articles and more. Click here for a full list.

60 Years of Experience

The panel of speakers consists of three of the industry’s most sought-out consultants and experts, with a combined 60 years of experience. They include:

John Avellanet, founder of an independent compliance consulting and training firm, Cerulean Associates LLC. He has earned international acclaim for his pragmatic FDA compliance advice.

Nancy Singer founded Compliance-Alliance LLC to specialize in professional development for FDA and industry staff. Previously she served as AdvaMed’s Special Counsel for FDA compliance and enforcement matters.

John “Jack” Garvey is the founder of Compliance Architects. He is a leading FDA regulatory, compliance and operations executive with more than 25 years of experience developing and leading quality, regulatory and compliance initiatives.

The Benefits of Attending

This informative conference will benefit drug, biotechs, biologics, diagnostics, cosmetics and device companies, as well as food and tobacco companies and any other organization regulated by the FDA. Attendees will include executive management, regulatory affairs personnel, quality assurance/quality control managers, legal and compliance officers, and directors of clinical research. Attendees will learn:

  • How to distinguish between fact and opinion
  • Who should avoid writing opinions on regulatory matters
  • The unrecognized dangers in casual emails
  • The information to include and exclude when writing meeting minutes
  • The problem with writing documents in the passive voice
  • How sticky notes on files can cause trouble for companies during a lawsuit
  • Words that will attract the attention of prosecutors or plaintiffs’ lawyers if a company is sued
  • How to write documents to reflect the company’s compliance activities

Register now. The complete workshop is only $1,797.

CONFERENCE DETAILS
FDA Recordkeeping, Dangerous Documents and Writing for Compliance ™
**Presented by FDAnews**
Nov. 13-14, 2013 – Bethesda, MD
http://www.fdanews.com/FDARecordkeeping

TUITION: $1,797

EASY WAYS TO REGISTER
Online:     http://www.fdanews.com/FDARecordkeeping
By phone: 888-838-5578 or 703-538-7600

ABOUT FDANEWS
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

Michelle Butler, FDANEWS, http://www/fdanews.com/FDARecordkeeping, +1 (703) 538-7665, [email protected]

Modal title

FDA Recordkeeping, Dangerous Documents and Writing for Compliance Brochure
View PDF
FDA Recordkeeping, Dangerous Documents and Writing for Compliance Brochure
FDA Recordkeeping, Dangerous Documents and Writing for Compliance Brochure

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.